Filing Details
- Accession Number:
- 0001140361-13-038710
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-10-15 16:39:39
- Reporting Period:
- 2013-10-11
- Filing Date:
- 2013-10-15
- Accepted Time:
- 2013-10-15 16:39:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 350907 | Thoratec Corp | THOR | Electromedical & Electrotherapeutic Apparatus (3845) | 942340464 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1354228 | Aaron David Lehman | 6035 Stoneridge Drive Pleasanton CA 94588 | Svp And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-10-11 | 16,000 | $17.91 | 64,966 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-10-11 | 16,000 | $38.17 | 48,966 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-10-11 | 5,889 | $38.17 | 43,077 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Qualified Stock Option (right to buy) | Disposition | 2013-10-11 | 16,000 | $0.00 | 16,000 | $17.91 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2008-02-13 | 2017-02-13 | No | 4 | M | Direct |
Footnotes
- Options were granted pursuant to the Company's equity incentive plan with no payments received for the options.
- Options vest in four equal annual installments commencing one year after the grant date.
- Options exercised and shares of Common Stock sold pursuant to a Sales Plan established by the Reporting Person on Septmeber 10, 2013, which Sales Plan is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Securities Exchange Act of 1934, as amended.
- This transaction was executed in multiple trades in prices ranging from $37.84 to $38.40. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
